Statin‐associated muscle symptoms—A review: Individualizing the approach to optimize care.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 5, p. 428, doi. 10.1002/phar.2681
- By:
- Publication type:
- Article
Works matching IS 02770008 AND DT 2022 AND VI 42 AND IP 5
Results: 8
1
2
Impact of timing and dosing of four‐factor prothrombin complex concentrate administration on outcomes in warfarin‐associated intracranial hemorrhage.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 5, p. 366, doi. 10.1002/phar.2680
- By:
- Publication type:
- Article
3
Impact of proton pump inhibitors on sustained virologic response in veterans treated with sofosbuvir/velpatasvir for chronic hepatitis C virus: A retrospective cohort study.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 5, p. 397, doi. 10.1002/phar.2682
- By:
- Publication type:
- Article
4
Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010–2016.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 5, p. 375, doi. 10.1002/phar.2679
- By:
- Publication type:
- Article
5
Contribution of pharmaceutical drugs of dependence to the incidence of neonatal abstinence syndrome in Western Australia between 2003 and 2018.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 5, p. 405, doi. 10.1002/phar.2678
- By:
- Publication type:
- Article
6
A propensity score‐matching analysis of angiotensin‐converting enzyme inhibitor and angiotensin receptor blocker exposure on in‐hospital mortality in patients with acute respiratory failure.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 5, p. 387, doi. 10.1002/phar.2677
- By:
- Publication type:
- Article
7
Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 5, p. 411, doi. 10.1002/phar.2676
- By:
- Publication type:
- Article
8
Issue Information.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 5, p. 363, doi. 10.1002/phar.2419
- Publication type:
- Article